Houston, TXNCT06689956Now EnrollingIRB Ready

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma Clinical Trial in Houston, TX

Access cutting-edge figo grade 1 endometrial endometrioid adenocarcinoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access figo grade 1 endometrial endometrioid adenocarcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related figo grade 1 endometrial endometrioid adenocarcinoma treatment provided free

Apply for This Houston Location

Check if you qualify for this figo grade 1 endometrial endometrioid adenocarcinoma clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma Study in Houston

This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Low-risk endometrial cancer, defined as endometrioid, grade 1 or 2, International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA (FIGO 2023 stages IA1 and IA2), without substantial/extensive LVSI (≥ 5 vessels involved) at final pathology. Patients with focal LVSI (\< 5 vessels involved) will be included.
Complete surgical staging, including pelvic sentinel lymph node (SLN) biopsy per National Comprehensive Cancer Network (NCCN) guidelines and ultrastaging.
Extent of disease in SLN: ITC (defined as tumor cell aggregates ≤ 0.2 mm or \< 200 cells)
No adjuvant treatment after surgery
Research consent provided.

Exclusion Criteria

Prior neoadjuvant chemotherapy.
Planning to receive adjuvant treatment.
Presence of synchronous cancer (excluding non-melanoma skin cancer).
Extent of disease in SLN: micrometastasis (\> 0.2 to ≤ 2.0 mm) or macrometastasis (\> 2.0 mm).
Presence of substantial/extensive LVSI (≥ 5 vessels involved) at final pathology.
Prior invasive cancer diagnosis within 5 years of study entry (excluding non-melanoma skin cancer).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT06689956) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma Treatment Options in Houston, TX

If you're searching for figo grade 1 endometrial endometrioid adenocarcinoma treatment options in Houston, TX, this clinical trial (NCT06689956) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced figo grade 1 endometrial endometrioid adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all figo grade 1 endometrial endometrioid adenocarcinoma clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Houston, TX

See all alzheimers disease clinical trials recruiting in Houston — not just this study.

Browse Alzheimers Disease Trials in Houston

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX